<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04043364</url>
  </required_header>
  <id_info>
    <org_study_id>NFR 273581</org_study_id>
    <nct_id>NCT04043364</nct_id>
  </id_info>
  <brief_title>Live@Home.Path: Innovating the Clinical Pathway for Home Dwelling Persons With Dementia and Their Families</brief_title>
  <acronym>LIVE</acronym>
  <official_title>LIVE@Home.Path: a Mixed Method, Stepped Wedge and Randomized Controlled Trial Innovating the Clinical Pathway for Home-dwelling Persons With Dementia and Their Families</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haraldsplass Deaconal Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Western Norway University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Reseach Centre AS (NORCE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian National Advisory Unit on Ageing and Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Natioal Association for Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Municipality of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Municipally of Kristiansund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Municipally of Bærum</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Dignity Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard McLean University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leiden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tohoku University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at developing, implementing and evaluating a complex intervention involving&#xD;
      Learning, Innovation, Volunteers and Empowerment for home dwelling persons with dementia and&#xD;
      their caregivers. The investigators hypothesise that a successfully implemented intervention&#xD;
      will reduce caregivers burden and be cost-effective.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The provision of economically viable and proper care for the growing group of home-dwelling&#xD;
      people with dementia (PWD) is one of the most pressing issues in our society. While a cure&#xD;
      for dementia is not yet available, professionals and policy-makers highly prioritize the&#xD;
      support of caregivers who experience a vast burden. However, there is a lack of high-quality&#xD;
      research investigating clinical, social and economic factors that may add beneficial effects.&#xD;
      This project aims to develop, test, and implement a complex intervention for PWD, intended to&#xD;
      reduce caregivers' burden, which will aid PWD to stay safely, longer and independently at&#xD;
      home with dignity and cost-effectiveness. The term informal caregivers' burden may include&#xD;
      different meanings for different people and be related to economic burden, depression and&#xD;
      anxiety, quality of life (QoL), or simply the quality of sleep and recreation. In a stepped&#xD;
      wedge, cluster randomized controlled trial, involving primary and secondary health care&#xD;
      systems in Bergen, Bærum and Kristiansand the 24-month LIVE@Home.Path study will be&#xD;
      undertaken in a stepped wedge design. The user-inspired and tailored intervention includes a&#xD;
      designated coordinator to the PWD and caregiver for 6 months to introduce a complex&#xD;
      intervention involving a) Learning b) Innovation c) Volunteers and d) Empowerment.&#xD;
&#xD;
      Qualitative interviews will determine users' values and wishes, and promotors and barriers&#xD;
      for successful implementation of the intervention. Primary and secondary outcomes on&#xD;
      cognitive, emotional and social factors, cost-benefit analyses, and QoL of PWD and families&#xD;
      will be assessed every 6-month over 2 years.&#xD;
&#xD;
      Update spring 2020: The COVID-19 pandemic severely hampered the implementation of the&#xD;
      intervention for the second group. We therefore had to change the design, postponing the&#xD;
      intervention in Bærum and Kristiansand, and delivering the intervention in Bergen by phone.&#xD;
      In addition, we initiated the PAN.DEM in the LIVE@Home.Path trial, collecting data from phone&#xD;
      interviews with caregivers on change in Health services and neuropsychiatric symptoms, risk&#xD;
      perception and restrictions. Changes in design approved by Ethical committee (REK: 10861).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Mixed method, stepped wedge randomized controlled trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resource Utilization in Dementia</measure>
    <time_frame>up to 24 months follow up, assesment every 6 months</time_frame>
    <description>RUD:A validated tool for assessment of time use for cost effectiveness analyses, measuring total time use in hours/day for different activities, numbers of contact points with care professionals and use of medications, high time use, many contacts and many medications indicates high resource use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative stress scale</measure>
    <time_frame>up to 24 months follow up, assessment every 6 months</time_frame>
    <description>RSS: measuring caregiver distress, 15 items ranging from 0-4, high score indicates high burden</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Activities of daily living, instrumental</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>I-ADL scale assessing instrumental activities such as use of telephone, economy, household, public transport and shopping, range from 8-31, higher score indicates poorer functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression and mood</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>CSDD: Cornell scale for depression in dementia, range 0-38, high score indicates high symptom load</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Agitation</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>CMAI: Cohen-Mansfield Agitation Inventory, 29 items assessing the frequency of agitated behaviour, range 29-203, high score indicates higher severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychiatric symptoms</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>NPI: presence, severity and burden of depression, anxiety, psychosis and motor disturbances, range from 0-144, high score indicates frequent, severe and burdensome symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>Falls, disappearances outdoor, admissions to acute wards, fire hazard</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of assistive technology</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>number of technical aids, cognitive intervention devices and assisted-living systems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of volunteers</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>number of participants with contact with a volunteer, number of hours spent with volunteer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of daily living, personal</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>P-ADL, assessing personal activities such as toileting, grooming, dressing, transfer and eating, scale range 6-30, higher score indicates poorer personal functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>EQ-5D-5L, Descriptive measure of health related quality of life comprising 5 Dimensions With 5 Levels each, scores can be converted to a single summary index number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life VAS scale</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>EQ-5D, Descriptive measure of quality of life rated on a VAS scale range 0-100, high score indicates good health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>QoL-AD: Quality of life in Alzheimer dementia, 13 items likert scale, range from 13-52 points, high score indicates high quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of volunteers</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>number of hours spent with a volunteer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change achieving</measure>
    <time_frame>at the start of intervention, and every 6 months</time_frame>
    <description>Clinical global impression of change, to quantify and track patient progress and treatment response on a scale from 1 to 7, at which 7 indicates substantial worsening.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver depression</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>GDS: Geriatric depression scale, 30 items rated yeas or no, high score indicates high burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comorbidity</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>GMHR: General medical health rating scale, 4 point likert scale, range from 1-4, high score indicates high comorbidity burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain in dementia</measure>
    <time_frame>24 months follow up, assesment every 6 months</time_frame>
    <description>MOBID-2: assesses the intensity of pain based on interpretation of pain related behaviour, range from 0-10, high score indicates high pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cognitive performance</measure>
    <time_frame>Baseline</time_frame>
    <description>IQ CODE: Proxy rater instrument for assessment of change in cognitive performance the last 10 years, range 16-80, high score indicates great decline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication use</measure>
    <time_frame>At the start of the intervention, and every 6 onth follow up</time_frame>
    <description>Self and proxy reported use of medications, both regular and on demand</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participation in educational programs</measure>
    <time_frame>24 months follow up, assessment every 6 months</time_frame>
    <description>Participation in educational programes, both for persons with dementia and for caregivers.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>COVID-19: risk perception</measure>
    <time_frame>month 6 to month 12 (during COVID-19 lock down in Norway)</time_frame>
    <description>Caregivers perception of risk of contamination With Sars-Cov-10</description>
  </other_outcome>
  <other_outcome>
    <measure>COVID-19: restrictions</measure>
    <time_frame>month 6 to month 12 (during COVID-19 lock down in Norway)</time_frame>
    <description>Change in services and contact due to restrictions of COVID-19</description>
  </other_outcome>
  <other_outcome>
    <measure>COVID-19: caregiver burden</measure>
    <time_frame>month 6 to month 12 (during COVID-19 lock down in Norway)</time_frame>
    <description>Caregivers perception of caregiver burden during COVID-19</description>
  </other_outcome>
  <other_outcome>
    <measure>COVID-19: neuropsychiatric symptoms</measure>
    <time_frame>month 6 to month 12 (during COVID-19 lock down in Norway)</time_frame>
    <description>NPI: change in presence, severity and burden of depression, anxiety, psychosis and motor disturbances</description>
  </other_outcome>
  <other_outcome>
    <measure>COVID-19: depression and mood</measure>
    <time_frame>month 6 to month 12 (during COVID-19 lock down in Norway)</time_frame>
    <description>CSDD: Change in cornell scale for depression in dementia.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Dementia</condition>
  <condition>Home-dwelling</condition>
  <condition>Caregiver</condition>
  <arm_group>
    <arm_group_label>LIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A multicomponent intervention focusing on Learning, Innovation, Volunteers and Empowerment organized by a local coordinator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Care coordination and facilitation as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LIVE</intervention_name>
    <description>Learning, Innovation, Volunteers and Empowerment</description>
    <arm_group_label>LIVE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Home-dwelling people with dementia (PWD) equal or above 65 years diagnosed according&#xD;
             to national guidelines&#xD;
&#xD;
          2. Mini mental state examination score 15-24&#xD;
&#xD;
          3. Functional Assessment Staging Test (FAST score 4-7)&#xD;
&#xD;
          4. Living with a partner, or have regular contact with a caregiver minimum 1 hour/week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participate in other trials&#xD;
&#xD;
          2. Expected survival under 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bettina Husebø, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bergen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Bergen</name>
      <address>
        <city>Bergen</city>
        <zip>5009</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32517727/</url>
    <description>Protocol</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/33416012/</url>
    <description>Access to and interest in assistive technology for home-dwelling people with dementia during the COVID-19 pandemic (PAN.DEM)</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/34536149/</url>
    <description>Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD).</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/34525979/</url>
    <description>Factors associated with access to assistive technology and telecare in home-dwelling people with dementia: baseline data from the LIVE@Home.Path trial</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/34551783/</url>
    <description>The consequences of COVID-19 lockdown for formal and informal resource utilization among home-dwelling people with dementia: results from the prospective PAN.DEM study</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32381282/</url>
    <description>Intensive Medicine and Nursing Home Care in Times of SARS CoV-2: A Norwegian Perspective</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32116687/</url>
    <description>Sensing Technology to Monitor Behavioral and Psychological Symptoms and to Assess Treatment Response in People With Dementia</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32753339/</url>
    <description>The Impact of Deprescribing Psychotropic Drugs on Behavioral and Psychological Symptoms and Daily Functioning in Nursing Home Patients</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/31986964/</url>
    <description>Fæø SE, Bruvik FK, Tranvåg O, Husebo BS. Home-dwelling persons with dementia's perception on care support</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/33198779/</url>
    <description>The compound role of a coordinator for home-dwelling persons with dementia and their informal caregivers: qualitative study</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/31170916/</url>
    <description>We live as good a life as we can, in the situation we're in&quot; - the significance of the home as perceived by persons with dementia.</description>
  </link>
  <reference>
    <citation>Husebo BS, Allore H, Achterberg W, Angeles RC, Ballard C, Bruvik FK, Fæø SE, Gedde MH, Hillestad E, Jacobsen FF, Kirkevold Ø, Kjerstad E, Kjome RLS, Mannseth J, Naik M, Nouchi R, Puaschitz N, Samdal R, Tranvåg O, Tzoulis C, Vahia IV, Vislapuu M, Berge LI. LIVE@Home.Path-innovating the clinical pathway for home-dwelling people with dementia and their caregivers: study protocol for a mixed-method, stepped-wedge, randomized controlled trial. Trials. 2020 Jun 9;21(1):510. doi: 10.1186/s13063-020-04414-y.</citation>
    <PMID>32517727</PMID>
  </reference>
  <reference>
    <citation>Gedde MH, Husebo BS, Erdal A, Puaschitz NG, Vislapuu M, Angeles RC, Berge LI. Access to and interest in assistive technology for home-dwelling people with dementia during the COVID-19 pandemic (PAN.DEM). Int Rev Psychiatry. 2021 Jun;33(4):404-411. doi: 10.1080/09540261.2020.1845620. Epub 2021 Jan 8.</citation>
    <PMID>33416012</PMID>
  </reference>
  <reference>
    <citation>Angeles RC, Berge LI, Gedde MH, Kjerstad E, Vislapuu M, Puaschitz NG, Husebo BS. Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD). Health Econ Rev. 2021 Sep 18;11(1):37. doi: 10.1186/s13561-021-00333-z. Review.</citation>
    <PMID>34536149</PMID>
  </reference>
  <reference>
    <citation>Puaschitz NG, Jacobsen FF, Mannseth J, Angeles RC, Berge LI, Gedde MH, Husebo BS. Factors associated with access to assistive technology and telecare in home-dwelling people with dementia: baseline data from the LIVE@Home.Path trial. BMC Med Inform Decis Mak. 2021 Sep 15;21(1):264. doi: 10.1186/s12911-021-01627-2.</citation>
    <PMID>34525979</PMID>
  </reference>
  <reference>
    <citation>Vislapuu M, Angeles RC, Berge LI, Kjerstad E, Gedde MH, Husebo BS. The consequences of COVID-19 lockdown for formal and informal resource utilization among home-dwelling people with dementia: results from the prospective PAN.DEM study. BMC Health Serv Res. 2021 Sep 22;21(1):1003. doi: 10.1186/s12913-021-07041-8.</citation>
    <PMID>34551783</PMID>
  </reference>
  <reference>
    <citation>Husebø BS, Berge LI. Intensive Medicine and Nursing Home Care in Times of SARS CoV-2: A Norwegian Perspective. Am J Geriatr Psychiatry. 2020 Jul;28(7):792-793. doi: 10.1016/j.jagp.2020.04.016. Epub 2020 Apr 22.</citation>
    <PMID>32381282</PMID>
  </reference>
  <reference>
    <citation>Husebo BS, Heintz HL, Berge LI, Owoyemi P, Rahman AT, Vahia IV. Sensing Technology to Monitor Behavioral and Psychological Symptoms and to Assess Treatment Response in People With Dementia. A Systematic Review. Front Pharmacol. 2020 Feb 4;10:1699. doi: 10.3389/fphar.2019.01699. eCollection 2019. Erratum in: Front Pharmacol. 2020 Mar 06;11:254.</citation>
    <PMID>32116687</PMID>
  </reference>
  <reference>
    <citation>Gedde MH, Husebo BS, Mannseth J, Kjome RLS, Naik M, Berge LI. Less Is More: The Impact of Deprescribing Psychotropic Drugs on Behavioral and Psychological Symptoms and Daily Functioning in Nursing Home Patients. Results From the Cluster-Randomized Controlled COSMOS Trial. Am J Geriatr Psychiatry. 2021 Mar;29(3):304-315. doi: 10.1016/j.jagp.2020.07.004. Epub 2020 Jul 11.</citation>
    <PMID>32753339</PMID>
  </reference>
  <reference>
    <citation>Fæø SE, Bruvik FK, Tranvåg O, Husebo BS. Home-dwelling persons with dementia's perception on care support: Qualitative study. Nurs Ethics. 2020 Jun;27(4):991-1002. doi: 10.1177/0969733019893098. Epub 2020 Jan 27.</citation>
    <PMID>31986964</PMID>
  </reference>
  <reference>
    <citation>Fæø SE, Tranvåg O, Samdal R, Husebo BS, Bruvik FK. The compound role of a coordinator for home-dwelling persons with dementia and their informal caregivers: qualitative study. BMC Health Serv Res. 2020 Nov 16;20(1):1045. doi: 10.1186/s12913-020-05913-z.</citation>
    <PMID>33198779</PMID>
  </reference>
  <reference>
    <citation>Fæø SE, Husebo BS, Bruvik FK, Tranvåg O. &quot;We live as good a life as we can, in the situation we're in&quot; - the significance of the home as perceived by persons with dementia. BMC Geriatr. 2019 Jun 6;19(1):158. doi: 10.1186/s12877-019-1171-6.</citation>
    <PMID>31170916</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2019</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Learning</keyword>
  <keyword>Innovation</keyword>
  <keyword>Volunteers</keyword>
  <keyword>Empowerment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We plan to make individual participant data available to collaborators and researchers affiliated with the project.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

